Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX7MEY
|
||||
| Drug Name |
N-((S)-4-cyclopentyl-1-((4S,7R)-7-methyl-3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-ylamino)-1-oxobutan-2-yl)morpholine-4-carboxamide
|
||||
| Synonyms |
CHEMBL1807700
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H39N5O6S
|
||||
| Canonical SMILES |
C[C@@H]1CC[C@H](NC(=O)[C@H](CCC2CCCC2)NC(=O)N3CCOCC3)C(=O)CN1S(=O)(=O)c4ccccn4
|
||||
| InChI |
InChI=1S/C26H39N5O6S/c1-19-9-11-21(23(32)18-31(19)38(35,36)24-8-4-5-13-27-24)28-25(33)22(12-10-20-6-2-3-7-20)29-26(34)30-14-16-37-17-15-30/h4-5,8,13,19-22H,2-3,6-7,9-12,14-18H2,1H3,(H,28,33)(H,29,34)/t19-,21+,22+/m1/s1
|
||||
| InChIKey |
BFGMUSWYFUOFKU-HJNYFJLDSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.